MB and rhabdomyolysis: While our observations suggest that the myoglobin/CK ratio could be useful as a risk assessment tool, further studies are needed to determine the scenarios that would benefit from the dual monitoring for predicting prognosis and guiding treatment decisions in rhabdomyolysis, as well as studies to clarify the mechanisms underlying prominent CK elevation without apparent skeletal muscle clinical manifestations.